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Objective: To explore the effect and mechanism of microRNA-208a (miR-208a) in the
mitochondrial apoptosis of cardiomyocytes of neonatal rats.
Methods: The primary cultured cardiomyocytes of neonatal rats were added into the
hypoxia incubator for the hypoxia induction. The overexpression system for miR-208a of
cardiomyocytes of neonatal rats was built. The ﬂow cytometry assay was employed to
detect the incidence of apoptosis in the over-expressed miR-208a. The mitochondrial
staining technique was used to detect the change in the mitochondrial morphology of
over-expressed miR-208a. The bioinformatic analysis was chosen to analyze and predict
the target gene of miR-208a.
Results: Firstly, the primary culture system of cardiomyocytes of neonatal rats was
successfully built. The miR-208a was over-expressed in cardiomyocytes of neonatal rats
by miR-208a Mimics. Results of ﬂow cytometry assay showed that the over-expressed
miR-208a could signiﬁcantly reduce the incidence of apoptosis; while results of mito-
chondrial staining indicated the change in the mitochondrial morphology of over-
expressed miR-208a and the mitochondrial ﬁssion process was inhibited. In conclu-
sion, it was supposed that miR-208a could inhibit the activation of mitochondrial ﬁssion
process to keep the cardiomyocytes from apoptosis.
Conclusions: The over-expressed miR-208a can reduce the incidence of apoptosis in the
cardiomyocytes of neonatal rats, signiﬁcantly change the mitochondrial morphology and
inhibit the mitochondrial ﬁssion process.1. Introduction
According to epidemiological studies, the cardiovascular dis-
ease was one of highest incidence of the disease in the world [1,2].
Most of cardiovascular diseases, including myocardial infarction,
angina and arrhythmia, were caused by the myocardial ischemia
and anoxia. The ischemic/anoxic heart diseases had the high
probability of disability and death, which severely harmed thehuman's health [3,4]. The cell apoptosis was the process of
physiological death in cells, while the ischemic/anoxic heart
diseases were accompanied with the abundant apoptosis death
of cardiomyocytes [5–7]. However, the molecular biological
mechanism for the incidence of ischemic/anoxic heart diseases
has not been clear. The molecular biological mechanism of the
hypoxia-induced cardiomyocytes apoptosis will be discussed in
this paper.
ThemicroRNAs (miRNA) is a kind of small non-coding single-
strand RNA with the length of about 18–25 nucleotides [8,9].
The ﬁrst miRNA (lin-4) was discovered by Lee et al in
Caenorhabditis elegans using the method genetic analysis
in 1993 [10,11]. Afterwards, the study on miRNA has become
the hot spot in the ﬁelds of biological science and basic medicine
in the past decade around the world. Several researches
indicated that miRNA-208a was some kind of miRNA withopen access article under the CC BY-NC-ND
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possessed the tissue speciﬁcity [12,13]. It's still not clear whether
miR-208a was involved in the regulation of ischemic/anoxic
heart diseases.
2. Materials and methods
2.1. Laboratory animals
One or two days SPF-grade SD neonatal rats, which were
purchased from Vital River Laboratories, were selected as the
objects. The feeding, management and related experiment of
animals were all strictly in accordance with Guide for the Care
and Use of Laboratory Animals, which was published by the
U.S. Department of Health and Human Services. The use of
laboratory animals in this study was approved by Laboratory
Animal Ethics Committee and the laboratory procedures were
strictly complied with Guide for the Care and Use of Labo-
ratory Animals that was published by U.S. Department of
Health and Human Services. Its aim is to relieve the suffering
of animals.
2.2. Isolation and culture of primary cardiomyocytes
One or two days SPF-grade SD neonatal rats were taken out
and anaesthetized. 75% ethanol was used to disinfect the skin of
rats. The skin of breast was cut open using the dissecting
scissors. Then the heart was taken out using the dissecting
tweezers and it was placed in the dish with the PBS buffer. The
vessels on the surface of heart and the atrium were removed.
Afterwards, the ventricle was cut into 1 mm3 tissue block using
the dissecting scissors. The tissue blocks were moved by the
pipettes into the digestive ﬂuid with 0.05% pancreatin and
0.025% collagenase II. It was then placed on the temperature-
controlled magnetic stirrer and digested for 9 times at 37 C,
with 5 min at each time. The complete culture solution with the
serum was used to stop the digestion. After the digestion, the
digestive ﬂuid was collected and centrifuged to get the car-
diomyocytes. The complete culture solution with 15% fetal
bovine serum was used to re-suspend the cells (the culture
medium also contained 0.1 mmol/L BrdU). 200-mesh ﬁlter was
used for the ﬁltration. The technique of differential velocity
adherent was performed for 90 min to remove the cardiac ﬁ-
broblasts. Finally, cardiomyocytes were seeded on 6-well plate
and it was placed in the cell culture incubator for 48 h of sta-
tionary culture. Afterwards, the ﬂuid was replaced by the serum-
free medium and it was moved to the hypoxic environment with
3% O2–5% CO2 (CO2 incubator) for 12 h to take the hypoxic
stimulation.
2.3. Transfection of cardiomyocytes of neonatal rats
As the chemosynthetic small fragments of nucleotides, the
miR-208a Mimics has the same nucleotide sequence with miR-
208a, which can over-express miR-208a in vivo; while Scramble
is the small fragments of nucleotides with the random order of
bases that acts as the control. After 48 h, the primary car-
diomyocytes of neonatal rats were transfected according to the
following procedures: in a well of 24-well plate, 20 pmol frag-
ments of nucleotides were dissolved in 50 mL serum-free me-
dium; then 1 mL transfection reagent Lipofectamine RNAiMAXwas dissolved in 50 mL serum-free medium and placed at the
room temperature for 5 min; the liquid in two Eppendorf tubes
was mixed and let it stand for 20 min. During that period, the
culture medium in 24-well plate was replaced by the serum-free
medium and 400 mL medium was added in each well. Finally,
the mixed solution was added in the corresponding well of 24-
well plate, with 100 mL in each well. It was placed in the
incubator for 6 h of culture. Then the culture medium in 24-well
plate was replaced by the normal medium. After 24 h of culture,
it continued the further operations. For instance, it was replaced
by the serum-free medium and moved to the hypoxic environ-
ment with 3% O2–5% CO2 (CO2 incubator) for 12 h to take the
hypoxic stimulation.
2.4. Real-time quantitative PCR
Extraction of RNA: the miRNA mini kit, which was pur-
chased from Beijing BLKW Biotechnology, was used to extract
the miRNA from cardiomyocytes and it should be operated
strictly in accordance with the instruction manual. Synthesis of
cDNA: the reverse transcription kit that purchased from Prom-
ega was used for the reverse transcription of miRNA and it
should be operated strictly in accordance with the instruction
manual. It should be specially noted that the primer of reverse
transcription had the speciﬁcity of miRNA. The reaction system
was incubated at 42 C for 15 min. Then samples were heated at
95 C for 5 min and placed at 0–5 C for 5 min. PCR Ampli-
ﬁcation: 1 mL cDNA template was used for the ﬂuorescent and
quantitative RT-PCR ampliﬁcation of miR-208a gene and U6
gene. SYBR 15 mL system included the target miRNA and
reference (U6) of each sample for Real-time PCR reaction.
2−△△Ct was used for the data analysis.
2.5. Western blot assay
The protein lysis buffer was used for the lysis of car-
diomyocytes of neonatal rats. The total protein was extracted
and its concentration was measured using BCA method. The
proper amount of protein was taken for 5% polyacrylamide gel
electrophoresis. When the bromophenol blue was moved to the
bottom of gel, the electrotransfection was performed and the
protein was transferred to PVDF ﬁlm. It was put in the 5% skim
milk room for 1 h. Then the primary antibodies of BAX (pur-
chased from Santa Cruz, No. sc-493), BCL-2 (purchased from
Santa Cruz, No. sc-783) and GAPDH (purchased from Santa
Cruz, No. sc-25778) were added at 4 C over night. Then it was
incubated by the secondary antibody for 2 h and ECL (pur-
chased from Millipore) was used for the luminescence.
2.6. Detection of apoptosis rate of cardiomyocytes by
ﬂow cytometry
After the certain period of culture, cells were digested by the
pancreatin and centrifuged at 800 rmp/min for 5 min. It was then
washed by pre-cooled PBS and centrifuged. The operation was
repeated twice. Afterwards, the binding buffer was used to re-
suspend the cells and separate them into single ones. Then
annexin and PI were added in the cell suspension. It was incu-
bated in a dark place and at room temperature for 15 min. Cells
were slightly shook and then the ﬂow cytometry was used to
detect the apoptosis rate.
Figure 2. Overexpression of miR-208a in cardiomyocytes of neonatal rats.
Con: no transfected nucleotide fragment; Scr: fragment of transfection
control group; Mimics: overexpression fragment of transfected miR-208a
(*P < 0.05).
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Cells were seeded on confocal dish. Mitotracker staining
agent that was purchased from Invitrogen was diluted by the
serum-free medium with the proportion of 1: 5 000. DAPI that
was purchased from Roche was diluted by the serum-free me-
dium with the proportion of 1: 5 000. Then it was placed in the
incubator at 37 C for 10 min. At the time of staining, the culture
medium was removed from the confocal dish. The dish was
washed by the serum-free medium three times. Then the pre-
pared staining solution was added in the confocal dish in a dark
place and it was incubated at the room temperature for 10 min.
After removing the staining solution, it was washed by PBS
three times and then photographed under the laser confocal
microscopy that was purchased from Olympus.
2.8. Statistical treatment
All experiments were repeated three times at least. The
experimental data was expressed by mean ± SD. SPSS was used
for the statistical treatment. The one-way analysis of variance
was employed for the comparison among groups and P < 0.05
referred to the statistical difference.
3. Results
3.1. Primary culture of cardiomyocytes of neonatal rats
For the separated cardiomyocytes of neonatal rats, the
Western blot technique was used to detect the expression of
important molecules a-MHC and b-MHC in cardiomyocytes, as
shown in Figure 1 Results showed that a-MHC and b-MHC in
cardiomyocytes of neonatal rats had the tendency of high
expression. Meanwhile, the expression of a-MHC and b-MHC
was detected in the cardiac ﬁbroblasts of control group. It
indicated that the primary culture system of cardiomyocytes of
neonatal rats was successfully built, which laid the foundation
for the further works.
3.2. Overexpression system of miR-208a
miR-208a Mimics was transfected into cardiomyocytes of
neonatal rats. The real-time quantitative PCR was used to detect
the expression of miR-208a. As shown in Figure 2, compared
with the cardiomyocytes with the transfected Scramble frag-
ments (the nucleotide fragment with the random order of bases
and as the control for miR-208a Mimics), the expression of miR-Figure 1. Expression of a-MHC and b-MHC in cardiomyocytes.
CM: cardiomyocytes; CF: cardiac ﬁbroblasts.208a in the transfection group of miR-208a Mimics was
increased by nearly ten times.
3.3. Effect of overexpression of miR-208a on expression
of BCL-2 and BAX
BCL-2 and BAX are two important proteins in the apoptosis,
where BCL-2 is to inhibit the apoptosis and BAX to promote the
apoptosis. As shown in Figure 3, results of Western blot assay
indicated that, under the hypoxic stimulation, the expression of
BCL-2 was signiﬁcantly increased after the overexpression of
miR-208a, while the expression of BAX was signiﬁcantly
decreased, which indicated that miR-208a could inhibit the
apoptosis.
3.4. Effect of overexpression of miR-208a on apoptosis
The ﬂow cytometry was used to detect the apoptosis rate. As
shown in Figure 4, under the hypoxic stimulation, the number of
annexin positive cells was signiﬁcantly reduced, while the
number of normal cells was increased, which indicated that the
overexpression of miR-208a could signiﬁcantly inhibit the
occurrence of hypoxia-induced apoptosis.
3.5. Effect of miR-208a on mitochondrial morphology of
cardiomyocytes
The mitochondrial ﬁssion was closely related to the
apoptosis. As shown in Figure 5, the mitochondrial morphology
in the normal cardiomyocytes of neonatal rats was regular,Figure 3. Change in expression of BCL-2 and BAX in miR-208a over-
expression group and control group.
Figure 4. Apoptosis rate in miR-208a overexpression group and control group.
Right upper quadrant and right lower quadrant were annexin Ⅴ positive cells.
Figure 5. Change in mitochondrial morphology in miR-208a overexpression group and control group.
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But under the hypoxic stimulation, the mitochondrial ﬁssion was
signiﬁcantly increased, which indicated the occurrence of
apoptosis. However, in the miR-208a overexpression group, the
number of cells with the mitochondrial ﬁssion was signiﬁcantly
decreased, which indicated the decreased apoptosis rate in
another way.
4. Discussion
In recent years, the study on miRNA in the heart diseases has
become the hot topic for the study on the mechanism of heart
diseases. According to previous researches, miRNA was
involved in the physiological process of apoptosis, electrical
conduction change, cardiomyocytes regeneration and cardiac
remodeling during the myocardial ischemia and anoxia [14–17].
Besides, several researches have explained the mechanism of
many miRNAs in the acute myocardial ischemia, which
provide the reference for the treatment of heart diseases
through the molecular drugs.
In addition, miRNA may also become the important bio-
logical marker for the myocardial injury, which would greatly
contribute to the early diagnosis and prevention of acute
myocardial infarction [18,19]. Lawrie et al found the miRNA in
the human serum in 2008 [20]. Since then, a great number of
researches have explained that the miRNA in the circulating
blood could stably exist in the extracellular ﬂuids such as
serum and plasma [21,22]. miR-208a is the cardiac-speciﬁc
miRNA, which can regulate the physiological and pathologicalprocess of generation, development and damage repair; and its
content is stable in the blood [23–26]. But in patients with the
heart diseases, the expression abundance of miR-208a in the
serum was signiﬁcantly increased, as an effective biological
marker for the early diagnosis of heart diseases [12,27,28].
In this study, the primary cultured cardiomyocytes of
neonatal rats in vitro was cultured in the hypoxia incubator and
the mode for the cardiomyocytes of neonatal rats anoxia was
built. Afterwards, the transfected small fragments of nucleotides
of miR-208a Mimics was to overexpress miR-208a and then the
related indicators of apoptosis were detected. Main assays
included the western blot detection of BCL-2 and BAX, ﬂow
cytometry after double straining of annexin Ⅴ/PI and Mito-
tracker to observe the mitochondrial morphology. These three
assays all conﬁrmed that the over-expressed miR-208a could
effectively inhibit the occurrence of apoptosis. Though there
have been abundant data about the anti-apoptosis function of
miR-208a, but its speciﬁc molecular biological mechanism has
not been clear.
According to the bioinformatic analysis, it's found that miR-
208a and miR-499 possessed the same seed sequence. Wang
et al reported that miR-499 could inhibit the dephosphorylation
of calcineurin-induced Drp1 protein, reduce the accumulation of
Drp1 in the mitochondria and inhibit the activation of Drp1-
induced mitochondrial ﬁssion, in order to keep the car-
diomyocytes from apoptosis [29]. According to Targetscan
bioinformatic websites [30,31], it's predicted that miR-208a
could be complementarily paired with 30UTR region of calci-
neurin mRNA, which indicated that miR-208a might also inhibit
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pathway, and thus inhibit the apoptosis. The focus of our further
study would be seeking the target gene of miR-208a and the
determination whether miR-208a actually inhibits the apoptosis
by acting on such target gene.
In conclusion, the high expression of cardiac-speciﬁc miRNA
in the heart and its abnormal expression in the apoptosis of
cardiomyocytes indicate its unique biological function. It is thus
possible to improve the symptoms by changing the expression of
these miRNAs, which provide the new opportunity for the
treatment of heart diseases.
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